Sort   by:  
 Page size 
Actionable loss of SLF2 drives B-cell lymphomagenesis and impairs CHK1 mediated DNA repair
The DNA damage response (DDR) acts as a barrier to malignant transformation and is often impaired during tumorigenesis. Exploiting the impaired DDR can be a promising therapeutic strategy; however, the mechanisms of inactivation and corresponding biomarkers are incompletely understood. Starting from...
ORGANISM(S): Homo sapiens (Human) 
2023-07-21 | PXD041834 | Pride
Silencing of unintegrated HIV-1 by SLF2 and the SMC5/6 complex
The DNA damage response (DDR) acts as a barrier to malignant transformation and is often impaired during tumorigenesis. Exploiting the impaired DDR can be a promising therapeutic strategy; however, the mechanisms of inactivation and corresponding biomarkers are incompletely understood. Starting from...
ORGANISM(S): Homo sapiens (Human) 
2023-07-21 | PXD041851 | Pride
Silencing of nuclear DNA is an essential feature of the innate immune response to invading pathogens. Early in lentiviral infection, unintegrated viral cDNA accumulates in the nucleus, yet remains poorly expressed. In HIV-1-like lentiviruses, the Vpr accessory protein enhances unintegrated viral DNA...
ORGANISM(S): Homo sapiens 
2021-03-01 | GSE156630 | GEO
Pathogenic variants in SLF2 and SMC5 cause a developmental disorder known as Atelis Syndrome, characterized by microcephaly, short stature, and hematological abnormalities, most notably anemia and lymphopenia. However, its clinical relevance to hematology has not yet been established, and the underl...
ORGANISM(S): Homo sapiens 
2026-08-06 | GSE316079 | GEO
Sort   by:  
 Page size